HCW TB cases (n=2320) | Non-HCW TB cases (n=27 681) | Chi squared p Value | |||
---|---|---|---|---|---|
n | Per cent | n | Per cent | ||
Sex | n=2295 | n=27 643 | |||
Male | 714 | 31.1 | 16 488 | 59.6 | <0.001 |
Age group (years) | n=2320 | n=27 681 | |||
16–24 | 126 | 5.5 | 5213 | 18.8 | <0.001 |
25–34 | 785 | 33.8 | 9273 | 33.5 | |
35–44 | 843 | 36.4 | 5976 | 21.6 | |
45–54 | 400 | 17.2 | 4161 | 15.0 | |
55–64 | 166 | 7.1 | 3057 | 11.0 | |
UK-born | n=2227 | n=27 075 | |||
Yes | 334 | 15.0 | 6138 | 22.7 | <0.001 |
Country of birth | n=2182 | 27 681 | |||
UK | 334 | 15.3 | 6138 | 23.0 | <0.001 |
India | 559 | 25.6 | 5913 | 22.2 | |
Pakistan | 128 | 5.9 | 3860 | 14.5 | |
Somalia | 31 | 1.4 | 1535 | 5.8 | |
Nigeria | 106 | 4.9 | 660 | 2.5 | |
Nepal | 74 | 3.4 | 654 | 2.4 | |
Zimbabwe | 200 | 9.2 | 459 | 1.7 | |
Philippines | 249 | 11.4 | 322 | 1.2 | |
Kenya | 44 | 2.0 | 331 | 1.2 | |
South Africa | 63 | 3.0 | 159 | 0.6 | |
All other countries | 394 | 18.1 | 6627 | 24.9 | |
Ethnicity | n=2252 | n=27 201 | |||
White | 270 | 12.0 | 4824 | 17.7 | <0.001 |
Black African | 644 | 28.6 | 4936 | 18.0 | |
Black Caribbean | 45 | 2.0 | 555 | 2.0 | |
Black other | 18 | 0.8 | 247 | 0.9 | |
Indian | 670 | 26.6 | 7201 | 26.5 | |
Pakistani | 171 | 7.6 | 4810 | 17.7 | |
Bangladeshi | 24 | 1.1 | 1169 | 4.3 | |
Chinese | 23 | 1.0 | 378 | 1.4 | |
Mixed/other | 387 | 17.2 | 3081 | 11.3 | |
Years since entry to the UK | n=1633 | n=18 906 | |||
<2 | 161 | 9.8 | 4188 | 22.2 | <0.001 |
2–5 | 473 | 29.0 | 5825 | 30.8 | |
6–10 | 624 | 38.4 | 3840 | 20.3 | |
>10 | 375 | 22.9 | 5053 | 26.7 | |
Site of disease | n=2312 | n=27 611 | |||
Pulmonary | 1005 | 43.5 | 14 423 | 52.2 | <0.001 |
Extrapulmonary only | 1307 | 56.5 | 13 188 | 47.8 | |
Social risk factor | n=1852 | n=22 221 | |||
Yes | 43 | 2.3 | 2754 | 12.4 | <0.001 |
Previous diagnosis | n=2219 | n=26 502 | |||
Yes | 97 | 4.4 | 1687 | 6.4 | <0.001 |
BCG vaccination* | n=1665 | n=19 356 | |||
Yes | 1456 | 87.5 | 14 282 | 73.8 | <0.001 |
Time to treatment start (pulmonary cases) | n=765 | n=10 631 | |||
<2 months after symptom onset | 337 | 44.0 | 4885 | 45.9 | 0.162 |
2–4 months after symptom onset | 214 | 28.0 | 3101 | 29.2 | |
>4 months after symptom onset | 214 | 28.0 | 2645 | 24.9 | |
Clustered (≥2 indistinguishable 24 loci MIRU-VNTR) | n=883 | n=11 554 | |||
Yes | 423 | 48.0 | 6402 | 55.4 | <0.001 |
MDR-TB | n=1425 | n=17 226 | |||
Yes | 20 | 1.4 | 285 | 1.7 | 0.473 |
*At any time. HCWs, healthcare workers; MIRU-VNTR, mycobacterial interspersed repetitive unit-variable number tandem; MDR-TB, multidrug-resistant TB.